SB
OM icon

Strategic Blueprint’s Outset Medical OM Stock Holding History

Strategic Blueprint’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,051
Closed -$407K – 544
2022
Q4 		$407K Buy
+1,051
New +$296K 0.05% 335
2021
Q3 		– Sell
-73
Closed -$55K – 1027
2021
Q2 		$55K Buy
+73
New +$55.8K 0.01% 590

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Strategic Blueprint's OM Position: Q1 2023 in Review

Strategic Blueprint sold out of Outset Medical (OM) in Q1 2023, closing a stake of 1,051 shares — an estimated $407K sold.

Strategic Blueprint first reported a position in OM in Q2 2021 and held it in 2 quarters. The position peaked at $407K in Q4 2022. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Strategic Blueprint reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
  • Strategic Blueprint sold 1,051 Outset Medical shares in Q1 2023, an estimated $407K.
  • Strategic Blueprint first reported a position in Outset Medical in Q2 2021 and held it in 2 quarters.
  • Strategic Blueprint's Outset Medical position peaked at $407K in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Strategic Blueprint's 13F filing for Q1 2023, filed 28 Apr 2023.